The Indigo Trial for Brain Cancer

The Indigo trial tested a novel targeted therapy called Varysidinib. It is an IDH1 and 2 inhibitor in patients with low-grade leomas who had surgery only as their prior therapy. If we are able to delay the need for treatments like radiation or chemotherapy for this group of patients, that is a significant advance for quality of life.